| Robert Kevin Butryn, MD | |
|
4033 Easter Sky Drive, Traverse City, MI 49684 | |
| (231) 932-9000 | |
| Not Available |
| Full Name | Robert Kevin Butryn |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 4033 Easter Sky Drive, Traverse City, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760584056 | NPI | - | NPPES |
| 3451490 10 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301064150 (Michigan) | Primary |
| Entity Name | Northern Vision Eye Care, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801998182 PECOS PAC ID: 8921101197 Enrollment ID: O20070308000031 |
News Archive
ScriptPro, of Mission, Kansas, and TCGRx, of Powers Lake, Wisconsin, announce that they will be exclusive partners in a distribution and co-marketing agreement allowing ScriptPro to bring TCGRx adherence packaging technologies to retail pharmacies throughout the United States.
LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.
Diabetes treatment regimens containing AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence of hypoglycemia in patients with Type 1 diabetes and poorly controlled blood sugar levels, according to a two-year study presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #283).
Emergency departments across the nation are failing to meet national goals in treating many heart attack and pneumonia patients, according to a study by Johns Hopkins researchers published in the October issue of Academic Emergency Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Kevin Butryn, MD 4033 Easter Sky Drive, Traverse City, MI 49684 Ph: (231) 932-9000 | Robert Kevin Butryn, MD 4033 Easter Sky Drive, Traverse City, MI 49684 Ph: (231) 932-9000 |
News Archive
ScriptPro, of Mission, Kansas, and TCGRx, of Powers Lake, Wisconsin, announce that they will be exclusive partners in a distribution and co-marketing agreement allowing ScriptPro to bring TCGRx adherence packaging technologies to retail pharmacies throughout the United States.
LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.
Diabetes treatment regimens containing AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence of hypoglycemia in patients with Type 1 diabetes and poorly controlled blood sugar levels, according to a two-year study presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #283).
Emergency departments across the nation are failing to meet national goals in treating many heart attack and pneumonia patients, according to a study by Johns Hopkins researchers published in the October issue of Academic Emergency Medicine.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 5 days ago
Dr. Matthew P Madion, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 929 Business Park Dr, Traverse City, MI 49686 Phone: 231-947-6246 Fax: 231-947-8864 | |
Dr. Timothy B. Hanley, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3830 W Front St, Traverse City, MI 49684 Phone: 231-929-3888 Fax: 231-929-4365 | |
Dr. Douglas J Covert, MD, MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 860 E Front St, Traverse City, MI 49686 Phone: 231-938-0710 Fax: 231-938-0264 | |
Dr. Alicia Morgan Eby, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5199 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-8101 Fax: 231-346-5926 | |
Diane Katherine Fiander, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 860 E Front St, Traverse City, MI 49686 Phone: 231-938-0710 Fax: 231-938-0264 | |
Dr. Robert F Stevenson, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3830 W Front St, Traverse City, MI 49684 Phone: 231-929-3888 Fax: 231-929-4365 | |
Nathan Farley, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 860 E Front St, Traverse City, MI 49686 Phone: 231-938-0710 Fax: 231-938-0264 |